Live Breaking News & Updates on International Cancer Research Partnership

Stay updated with breaking news from International cancer research partnership. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Urgent action needed to address weaknesses in European cancer research

Urgent action needed to address weaknesses in European cancer research
sciencex.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencex.com Daily Mail and Mail on Sunday newspapers.

Michel Coleman , Mark Lawler , Claudia Allemani , Lancet Oncology Commission , London School Of Hygiene Tropical Medicine , Cancer Survival Group , International Cancer Research Partnership , Lancet Oncology European Groundshot Commission , London School , Tropical Medicine , Professor Michel Coleman , European Groundshot , Lancet Oncology ,

Urgent action needed to address weaknesses in European cancer research

Europe may face a ‘cancer epidemic’ over the next decade if immediate action is not taken to address weaknesses in health infrastructure and gaps in research, warn scientists in a new report published in The Lancet Oncology. Led by almost 50 experts including researchers from the London School of Hygiene & Tropical Medicine (LSHTM)  the Lancet Oncology European Groundshot Commission considered over 12 years of data on cancer research activity. ....

United States , City Of , United Kingdom , Michel Coleman , Claudia Allemani , London School Of Hygiene Tropical Medicine , Cancer Survival Group , International Cancer Research Partnership , Lancet Oncology European Groundshot Commission , London School , Tropical Medicine , Professor Michel Coleman , European Groundshot , Lancet Oncology , European Cancer Summit , London Global Cancer ,

European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

Cancer research is a crucial pillar for countries to deliver more affordable, higher
quality, and more equitable cancer care. Patients treated in research-active hospitals
have better outcomes than patients who are not treated in these settings. However,
cancer in Europe is at a crossroads. Cancer was already a leading cause of premature
death before the COVID-19 pandemic, and the disastrous effects of the pandemic on
early diagnosis and treatment will probably set back cancer outcomes in Europe by
almost a decade. ....

United Kingdom , United States , Le Chatelier , Champagne Ardenne , Nord Pas De Calais , Krasnoyarskiy Kray , Permskiy Kray , New York , White House , District Of Columbia , Good Friday , New South Wales , Le Chevalier , Provence Alpes Côd Azur , Noord Brabant , L Vivs Ka Oblast , World Bank , Russian Federation , Molina Barcel , Van Hemelrijck , Murphy Jr , Carnall Farrar , Gastroenterol Hepatol , International Standard Of Quality Cancer Care , International Cancer Research Partnership , Eurj Health Econ ,